tirzepatide cause dizziness Mounjaro & Vertigo: Is It a Real Side Effect? Causes and consequences of discontinuation

These events included nausea, diarrhea and vomiting." An analyst asked on the Lilly conference call today, whether the higher doses are workable

It is not a diagnostic device or a substitute for medical supervision

GLP-1 receptor activation in the hypothalamus reduces hunger signals and increases satiety, while delayed gastric emptying prolongs the feeling of fullness after meals

More recently, tirzepatide, a once-weekly injectable dual agonist targeting both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors, has shown improvements in glycemic control and weight reduction across a broad spectrum of patients with type 2 diabetes, including those at elevated CVD risk [15, 16]